semaglutide shortage 2025 End of Means Big Changes for Prescribers and Compounders semaglutide shortage 2025 Semaglutide Market

Rare side effects include stomach paralysis, inflammation of the pancreas or an obstruction in the small bowel

They are not FDA-approved and have not gone through the review process applied to brand-name drugs

"The current valuation reflects investors' confidence in the long-term strength of the company's metabolic health drug platform

Patients need a lot of counseling and support. Ultimately, temporarily stopping GLP-1 medication doesnt mean you are changing your personal health goals

In clinical studies, semaglutide lowered HbA1c, a measure of average blood sugar over 2 to 3 months, by about 1.2 to 1.8 percentage points, showing meaningful improvement in glucose control